Jahangir Cyrus, MD
Basic profileEndocrinology, Diabetes & Metabolism
Jahangir Cyrus is an Endocrinology/Metabolic physician. OpenAlex indexes 15 publications with 279 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20255 payments$1,620
- Medtronic, Inc.Program year20251 payment$66
- Axsome Therapeutics, Inc.Program year20251 payment$16
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
51.5%SGLT2 inhibitor13.2%Jardiance62%Farxiga23%Synjardy8%Synjardy Xr8%Part D≥87 patientsDPP-4 inhibitor10.4%Janumet35%Tradjenta23%Januvia19%Jentadueto9%Janumet Xr9%Jentadueto Xr6%Part D≥33 patients+ 8 more classes in this area
Cardiovascular
33.3%Statin9%Rosuvastatin Calcium52%Atorvastatin Calcium40%Pravastatin Sodium6%Simvastatin3%Part D<11 patientsAngiotensin receptor blocker (ARB)4.4%Losartan Potassium22%Olmesartan-Hydrochlorothiazide22%Olmesartan Medoxomil19%Irbesartan16%Telmisartan13%Losartan-Hydrochlorothiazide8%Part D<11 patients+ 14 more classes in this area
Musculoskeletal
4.4%Xanthine oxidase inhibitor3.8%Allopurinol100%Part D≥53 patientsCentral alpha-2 Adrenergic Agonist0.3%Tizanidine Hcl100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- PROPERTY OF HEALTH SCIENCES LIBRARY2016
- Evaluation of the tourniquet test as a predictor of diabetic retinopathy
Journal of Diabetes and its Complications
1991 - The effect of an aldose reductase inhibitor on cardiovascular performance in patients with diabetes mellitus
Diabetes Research and Clinical Practice
1990 - Autonomic influence on cardiovascular performance in diabetic subjects
The American Journal of Medicine
1989
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”